OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, today announces its participation in the ...
Everyday Health on MSN
What’s next in obstructive hypertrophic cardiomyopathy treatment?
From next-generation medications to groundbreaking gene therapies and nonsurgical procedures, explore the pipeline of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results